← Back to all stories

HIMS Shares Sink After FDA Vows "Swift Action" Against Copycat GLP-1 Drugs

HIMS Shares Sink After FDA Vows "Swift Action" Against Copycat GLP-1 Drugs Hims & Hers Health's $49-a-month copycat GLP-1 pill, priced far below Novo Nordisk's $149-a-month Wegovy pill, can be seen as part of a "GLP-1 price war" between the telehealth company and Big Pharma giant. It appears that HIMS'…
Zerohedge • 10 hours ago

Share this story:

LinkedIn Reddit
Read full article at Zerohedge →

►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None